Investor outrage about excessive executive compensation rears its head from time to time, but STERIS (NYSE:STE) shareholders are unlikely to shake their fists at CEO Walt Rosebrough’s pay package. That’s because Rosebrough’s pay dropped 29 percent to about $2.2 million in STERIS’ fiscal year ended March 31, 2012, compared with the prior year. Rosebrough’s base […]
Medical device company STERIS (NYSE:STE) is viewing its recently started fiscal 2013 as a “turning point” for the company, as it moves beyond a lengthy and costly transition from its flagship sterilization system. Mentor, Ohio-based STERIS experienced several challenges to its bottom line last year, including costs associated with moving customers to its System 1E, […]
Help shape the future of healthcare benefits by sharing your insights.
STERIS (NYSE:STE) has launched a new room biodecontamination device aimed at life sciences customers such as animal research labs and biotechnology companies. Mentor, Ohio-based STERIS’ new device, called the VHP Victory Room Biodecontamination Unit, uses dry, vaporized hydrogen peroxide to sterilize a room as well as the equipment in it. A customer might use the […]
Medical device company STERIS (NYSE:STE) has received long-awaited U.S. Food and Drug Administration clearance on an accessory part for its System 1E liquid chemical sterilization device. The newly cleared product, the Verify Spore Test Strip, is an optional part that’s used to monitor the sterility of a chemical cleaning agent used in the system. The […]
STERIS (NYSE:STE) has received 510(k) clearance from the U.S. Food and Drug Administration for software modifications to its System 1E liquid chemical sterilization system. The modifications are related to system aborts that were caused primarily by water-temperature issues, STERIS spokesman Steve Norton said. The System 1E is a liquid chemical sterilizing system used by hospitals, […]
Sterilization products maker STERIS (NYSE:STE) reported that shipments of its System 1E sterilizer continue to fall below the company’s earlier projections. The Mentor, Ohio-based company now projects that it’ll ship 4,000 System 1E units in its fiscal 2012, which is scheduled to end on March 31, company executives said Tuesday in a conference call to […]
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
The U.S. Food and Drug Administration has extended by six months a deadline for STERIS (NYSE:STE) to support customers transitioning from its System 1 sterilizer, for which the FDA revoked approval two years ago. Under terms of the new agreement, some System 1 customers can continue to purchase a consumable sterilant used by the system […]
Sterilization products maker STERIS (NYSE:STE) has opened a new European headquarters in Bordeaux, France. The Bordeaux headquarters brings together marketing, research and development, manufacturing, and sales and customer services. The Mentor, Ohio-based company’s goal is to foster collaboration between the disparate groups to more rapidly develop new products, Cleanroom Technology reported. About 150 employees, some […]
STERIS (NYSE:STE) and Toshiba America Medical Systems have struck a deal to collaborate on creating “hybrid” operating rooms for hospital customers. Selling equipment for hybrid operating rooms is expected to be an increasingly important revenue generator for Mentor, Ohio-based STERIS, which has seen a surge in demand surrounding this next-generation surgical suites. Hybrid operating rooms […]
In the hopes of reversing the trend of “disappointing” sales of its replacement flagship sterilization device, STERIS (NYSE:STE) is eagerly awaiting FDA clearance of an accessory part for the device. But unfortunately for the Mentor, Ohio-based company, STERIS has had to keep waiting (… and waiting … and waiting) to begin marketing the part — […]
The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.
STERIS (NYSE:STE) has a launched an enhanced version of a low-temperature sterilization system for surgical instruments. The Mentor, Ohio, company received 510(k) clearance from the U.S. Food and Drug Administration in September for its new Amsco V-PRO maX Low Temperature Sterilization System. The system offers three processing cycles to better accommodate a wide variety of […]
Sterilization products maker STERIS (NYSE:STE) is experiencing a more slow and costly transition to a new version of its flagship sterilization system than the company expected. The company had earlier projected between 5,000 and 8,000 sales on the year of its new System 1E, a liquid chemical sterilizing system used by hospitals, surgical centers and […]
STERIS (NYSE:STE) has obtained 510(k) clearance from the U.S. Food and Drug Administration on two new sterilization devices and one clearance for a minor enhancement on an existing product. Details of the new products were fairly sketchy, as a STERIS spokesman declined to provide much information until after the products are launched at an unspecified […]
Sterilization products company STERIS (NYSE:STE) is looking to hire more than 50 employees at its suburban Cleveland headquarters, with a particular emphasis on engineers. The healthcare jobs hiring binge is part of the company’s plan to add about 300 positions to its Mentor, Ohio headquarters in the coming years. The hires are related to the […]
The top executive with sterilization products maker STERIS (NYSE:STE) said the transition to a replacement version of its flagship sterilization device is “moving along as expected.” The Mentor, Ohio-based company during the most recent quarter shipped 700 units of its new System 1E device, which is a liquid chemical sterilizing system used by hospitals, surgical […]